Last reviewed · How we verify
NCT03433651
Creatine Monohydrate Use for Preventing Altitude Induced Depression
Phase 4 trial testing Creatine monohydrate in Depression. Withdrawn.
7 January 2019
Quick facts
| Lead sponsor | Mike O'Callaghan Military Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Start date | 1 January 2019 |
| Primary completion | 7 January 2019 |
| Estimated completion | 7 January 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Creatine monohydrate — full drug profile →
- Placebo
Conditions studied
- Depression — all drugs for Depression →
Sponsor
Mike O'Callaghan Military Hospital
Who can join
Adults 18 to 65, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study involves the use of an investigational drug called Creatine Monohydrate. This means that the drug has not yet been approved by the Food \& Drug Administration (FDA) for treatment of altitude-induced depression. However, the FDA has not objected to its use to study its safety and effectiveness for preventing altitude-induced depression. This study will help find out what effects, good and/or bad, Creatine Monohydrate has on treating symptoms for altitude-induced depression. Creatine Monohydrate is believed to have an effect on improving symptoms of depression. The safety of Creatine Monohydrate in humans has been tested in prior research studies; however, some side effects may not yet be known.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03433651
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Creatine monohydrate
Trials testing the same drug.
- NCT07310043 — Creatine and Perioperative Brain Health · NA · not yet recruiting
- NCT06992414 — Exploring the Therapeutic Effects of Creatine Supplementation for Long COVID-19 · NA · not yet recruiting
- NCT06576466 — Effect of Supplementation With Creatine on the Recovery of Ischemic Stroke · NA · recruiting
- NCT06438887 — Strategic Ingestion of Creatine Supplementation and Resistance Training in Trained Young Adults · NA · recruiting
- NCT04395183 — 5-HTP and Creatine for Depression · Phase 2 · completed
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other Mike O'Callaghan Military Hospital trials
Trials by the same sponsor.
- NCT03747549 — Acupuncture for Insertional Achilles Tendinopathy Effectiveness · NA · completed
- NCT02929589 — Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy · Phase 3 · terminated
- NCT03246087 — Acupuncture for Plantar Fasciosis in the Primary Care Setting · NA · completed
- NCT02761018 — Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes · NA · completed
- NCT02273193 — Utility Of Hemoglobin A1C For The Diagnosis Of Gestational Diabetes · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03433651 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mike O'Callaghan Military Hospital
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03433651.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing